Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Antonio Bertoletti, Anthony T. Tan, Nina Le Bert
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1418-1423
Open Access | Times Cited: 351
COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 180
SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 114
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay
Viruses (2022) Vol. 14, Iss. 1, pp. 79-79
Open Access | Times Cited: 76
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
Soumya Jaganathan, Francis Stieber, Sonia N. Rao, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 2765-2776
Open Access | Times Cited: 77
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti, Linda Petrone, Davide Manissero, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1784-1789
Open Access | Times Cited: 59
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
Megan Schwarz, Denis Torre, Daniel Lozano‐Ojalvo, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 11, pp. 1680-1689
Open Access | Times Cited: 38
The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 37
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Meng Yu, Afandi Charles, Alberto Cagigi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response
Daniela Huzly, Marcus Panning, Franziska Smely, et al.
Journal of Clinical Virology (2022) Vol. 148, pp. 105098-105098
Open Access | Times Cited: 29
T cell immunity is key to the pandemic endgame: How to measure and monitor it
Megan Schwarz, Slim Mzoughi, Daniel Lozano‐Ojalvo, et al.
Current Research in Immunology (2022) Vol. 3, pp. 215-221
Open Access | Times Cited: 27
T‐Cell‐Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS‐CoV‐2 Infection
Wenyan Fu, Wei Zhang, Zuhui You, et al.
Advanced Science (2025)
Open Access
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination
Marta Fernández‐González, Vanesa Agulló, Sergio Padilla, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e338-e346
Open Access | Times Cited: 32
Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
Martin Qui, Nina Le Bert, Webber Chan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 26
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Lil Meyer-Arndt, Julian Braun, Florent Fauchère, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 9, pp. 960-971
Open Access | Times Cited: 26
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study
Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
Rohan Ameratunga, See-Tarn Woon, A. M. Jordan, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 5, pp. 421-430
Closed Access | Times Cited: 30
Immune responses in COVID-19 and tuberculosis coinfection: A scoping review
Kevin Flores-Lovon, Brando Ortiz-Saavedra, Luis A. Cueva-Chicaña, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Spatially distributed infection increases viral load in a computational model of SARS-CoV-2 lung infection
Melanie Moses, Steven Hofmeyr, Judy L. Cannon, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 12, pp. e1009735-e1009735
Open Access | Times Cited: 23
iNKT cell agonists as vaccine adjuvants to combat infectious diseases
Yaqian Li, Cheng Yan, Rui Luo, et al.
Carbohydrate Research (2022) Vol. 513, pp. 108527-108527
Closed Access | Times Cited: 17
T cell control of SARS-CoV-2: When, which, and where?
Mariana O. Diniz, Mala K. Maini, Leo Swadling
Seminars in Immunology (2023) Vol. 70, pp. 101828-101828
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top